Jaguar Health (JAGX) Net Cash Flow Growth (1y) (2015 - 2026)
Jaguar Health (JAGX) Net Cash Flow Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 301.06% |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 453.08% |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | -125.22% |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | 53.46% |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | 194.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 194.34% |
| Dec 31, 2025 | 182.81% |
| Sep 30, 2025 | 155.85% |
| Jun 30, 2025 | -180.38% |
| Mar 31, 2025 | -144.97% |
| Dec 31, 2024 | -262.89% |
| Sep 30, 2024 | 47.76% |
| Jun 30, 2024 | 177.28% |
| Mar 31, 2024 | -41.11% |
| Dec 31, 2023 | 162.16% |
| Sep 30, 2023 | -444.49% |
| Jun 30, 2023 | 20.97% |
| Mar 31, 2023 | 1,848.57% |
| Dec 31, 2022 | -210.05% |
| Sep 30, 2022 | 108.00% |
| Jun 30, 2022 | -2,071.99% |
| Mar 31, 2022 | -98.12% |
| Dec 31, 2021 | -30.63% |
| Sep 30, 2021 | -1,072.69% |
| Jun 30, 2021 | -123.51% |